Ammonium Hydroxide → 6-(2-ethyl-1-(1H-imidazol-1-yl)butyl)benzo[d]thiazol-2-amine

HRID 538886Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 538886
[CH2:1]([CH:3]([CH2:17][CH3:18])[CH:4]([C:10]1[CH:16]=[CH:15][C:13]([NH2:14])=[CH:12][CH:11]=1)[N:5]1[CH:9]=[CH:8][N:7]=[CH:6]1)[CH3:2].[C:19]([S-:21])#[N:20].[K+].BrBr.[NH4+].[OH-]>CC(O)=O>[CH2:17]([CH:3]([CH2:1][CH3:2])[CH:4]([C:10]1[CH:11]=[CH:12][C:13]2[N:14]=[C:19]([NH2:20])[S:21][C:15]=2[CH:16]=1)[N:5]1[CH:9]=[CH:8][N:7]=[CH:6]1)[CH3:18]

Komponenten

6

Versuchsvorschrift

A solution of 4-(2-ethyl-1-(1H-imidazol-1-yl)butyl)aniline (285 mg, 1.17 mmol) and KSCN (455 rug, 4.68 mmol) in AcOH (6 mL) was stirred until all dissolved at RT and then treated with Br2 (0.063 mL, 1.23 mmol) in AcOH (2 mL) added drop wise via syringe over 5 min. The reaction mixture was stirred overnight at RT. The reaction mixture was diluted with ice water and then basified with NH4OH (pH 12). The aqueous phase was extracted three times with DCM and the organic extracts were combined and dried over filtered and then concentrated. The crude product was purified by preparative TLC using 5% MeOH in DCM as eluent to afford to 6-(2-ethyl-1-(1H-imidazol-1-yl)butyl)benzo[d]thiazol-2-amine as pale yellow solid. MS (ES+): 301.27 (MH+).

Aufarbeitung

  1. dissolutionall dissolved at RT
  2. additionadded drop wise via syringe over 5 min
  3. extractionThe aqueous phase was extracted three times with DCM
  4. customdried
  5. filtrationover filtered
  6. concentrationconcentrated
  7. customThe crude product was purified by preparative TLC

Quellen und Nachweise

ORD-Eintrag
ord-cd7b110de2144c1796a2e9bcad9a8cd1
Quelldatensatz
uspto-grants-2014_10
Patentnummer
US08865752B2

Notizen zur Reaktion

Wird geladen…